カテゴリ： GlobalInfoResearch, 世界, 部品/材料

世界のダビガトランエテキシレートメシル酸API市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Dabigatran Etexilate Mesylate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM0468）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM0468
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：124
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のダビガトランエテキシレートメシル酸API市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のダビガトランエテキシレートメシル酸APIの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のダビガトランエテキシレートメシル酸API市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- ダビガトランエテキシレートメシル酸APIの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

ダビガトランエテキシレートメシル酸API市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・純度≧99%、純度<99%

用途別セグメント
・カプセル、その他

主要な市場プレーヤー
・Hetero Drugs Ltd、Aurobindo Pharma Ltd、Neuland Laboratories Ltd、Zydus Lifesciences Ltd、Alkem Laboratories Ltd、Teva Pharmaceutical Industries Ltd、Lupin Ltd、Dr Reddys Laboratories Ltd、Apotex Pharmachem India Pvt Ltd、Glenmark Life Sciences Ltd、Alembic Pharmaceuticals Ltd、Msn Laboratories Private Ltd、Metrochem Api Private Ltd、Lee Pharma Ltd、Msn Life Sciences Private Ltd、Optimus Drugs Private Ltd、Yabao Pharmaceutical Group Co Ltd、Acebright India Pharma Private Ltd、Srini Pharmaceuticals Private Ltd、Biocon Ltd、Jubilant Generics Ltd、Solara Active Pharma Sciences Ltd、Piramal Pharma Ltd、Micro Labs Ltd、Sun Pharmaceutical Industries Ltd、Zhejiang Huahai Pharmaceutical Co Ltd、Sichuan Qingmu Pharmaceutical Co Ltd、Jiangxi Synergy Pharmaceutical Co Ltd、Changzhou Pharmaceutical Factory、Hisun Pharmaceutical Nantong Co Ltd

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ダビガトランエテキシレートメシル酸API製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なダビガトランエテキシレートメシル酸APIメーカーの企業概要、2019年～2022年までのダビガトランエテキシレートメシル酸APIの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なダビガトランエテキシレートメシル酸APIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ダビガトランエテキシレートメシル酸APIの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのダビガトランエテキシレートメシル酸APIのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのダビガトランエテキシレートメシル酸API市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびダビガトランエテキシレートメシル酸APIの産業チェーンを掲載しています。
・第14、15章では、ダビガトランエテキシレートメシル酸APIの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– ダビガトランエテキシレートメシル酸APIの概要
– タイプ別分析（2018年vs2022年vs2029年）：純度≧99%、純度<99% - 用途別分析（2018年vs2022年vs2029年）：カプセル、その他 - 世界のダビガトランエテキシレートメシル酸API市場規模・予測 - 世界のダビガトランエテキシレートメシル酸API生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Hetero Drugs Ltd、Aurobindo Pharma Ltd、Neuland Laboratories Ltd、Zydus Lifesciences Ltd、Alkem Laboratories Ltd、Teva Pharmaceutical Industries Ltd、Lupin Ltd、Dr Reddys Laboratories Ltd、Apotex Pharmachem India Pvt Ltd、Glenmark Life Sciences Ltd、Alembic Pharmaceuticals Ltd、Msn Laboratories Private Ltd、Metrochem Api Private Ltd、Lee Pharma Ltd、Msn Life Sciences Private Ltd、Optimus Drugs Private Ltd、Yabao Pharmaceutical Group Co Ltd、Acebright India Pharma Private Ltd、Srini Pharmaceuticals Private Ltd、Biocon Ltd、Jubilant Generics Ltd、Solara Active Pharma Sciences Ltd、Piramal Pharma Ltd、Micro Labs Ltd、Sun Pharmaceutical Industries Ltd、Zhejiang Huahai Pharmaceutical Co Ltd、Sichuan Qingmu Pharmaceutical Co Ltd、Jiangxi Synergy Pharmaceutical Co Ltd、Changzhou Pharmaceutical Factory、Hisun Pharmaceutical Nantong Co Ltd ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・タイプ別分析2018年-2029年：純度≧99%、純度<99% ・用途別分析2018年-2029年：カプセル、その他 ・ダビガトランエテキシレートメシル酸APIの北米市場 - タイプ別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ダビガトランエテキシレートメシル酸APIのヨーロッパ市場 - タイプ別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ダビガトランエテキシレートメシル酸APIのアジア市場 - タイプ別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ダビガトランエテキシレートメシル酸APIの南米市場 - タイプ別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ダビガトランエテキシレートメシル酸APIの中東・アフリカ市場 - タイプ別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Dabigatran Etexilate Mesylate API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dabigatran Etexilate Mesylate API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity≥99%
1.3.3 Purity<99% 1.4 Market Analysis by Application 1.4.1 Overview: Global Dabigatran Etexilate Mesylate API Consumption Value by Application: 2018 Versus 2022 Versus 2029 1.4.2 Capsule 1.4.3 Others 1.5 Global Dabigatran Etexilate Mesylate API Market Size & Forecast 1.5.1 Global Dabigatran Etexilate Mesylate API Consumption Value (2018 & 2022 & 2029) 1.5.2 Global Dabigatran Etexilate Mesylate API Sales Quantity (2018-2029) 1.5.3 Global Dabigatran Etexilate Mesylate API Average Price (2018-2029) 2 Manufacturers Profiles 2.1 Hetero Drugs Ltd 2.1.1 Hetero Drugs Ltd Details 2.1.2 Hetero Drugs Ltd Major Business 2.1.3 Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Product and Services 2.1.4 Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.1.5 Hetero Drugs Ltd Recent Developments/Updates 2.2 Aurobindo Pharma Ltd 2.2.1 Aurobindo Pharma Ltd Details 2.2.2 Aurobindo Pharma Ltd Major Business 2.2.3 Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services 2.2.4 Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.2.5 Aurobindo Pharma Ltd Recent Developments/Updates 2.3 Neuland Laboratories Ltd 2.3.1 Neuland Laboratories Ltd Details 2.3.2 Neuland Laboratories Ltd Major Business 2.3.3 Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services 2.3.4 Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.3.5 Neuland Laboratories Ltd Recent Developments/Updates 2.4 Zydus Lifesciences Ltd 2.4.1 Zydus Lifesciences Ltd Details 2.4.2 Zydus Lifesciences Ltd Major Business 2.4.3 Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Product and Services 2.4.4 Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.4.5 Zydus Lifesciences Ltd Recent Developments/Updates 2.5 Alkem Laboratories Ltd 2.5.1 Alkem Laboratories Ltd Details 2.5.2 Alkem Laboratories Ltd Major Business 2.5.3 Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services 2.5.4 Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.5.5 Alkem Laboratories Ltd Recent Developments/Updates 2.6 Teva Pharmaceutical Industries Ltd 2.6.1 Teva Pharmaceutical Industries Ltd Details 2.6.2 Teva Pharmaceutical Industries Ltd Major Business 2.6.3 Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services 2.6.4 Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates 2.7 Lupin Ltd 2.7.1 Lupin Ltd Details 2.7.2 Lupin Ltd Major Business 2.7.3 Lupin Ltd Dabigatran Etexilate Mesylate API Product and Services 2.7.4 Lupin Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.7.5 Lupin Ltd Recent Developments/Updates 2.8 Dr Reddys Laboratories Ltd 2.8.1 Dr Reddys Laboratories Ltd Details 2.8.2 Dr Reddys Laboratories Ltd Major Business 2.8.3 Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services 2.8.4 Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.8.5 Dr Reddys Laboratories Ltd Recent Developments/Updates 2.9 Apotex Pharmachem India Pvt Ltd 2.9.1 Apotex Pharmachem India Pvt Ltd Details 2.9.2 Apotex Pharmachem India Pvt Ltd Major Business 2.9.3 Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Product and Services 2.9.4 Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.9.5 Apotex Pharmachem India Pvt Ltd Recent Developments/Updates 2.10 Glenmark Life Sciences Ltd 2.10.1 Glenmark Life Sciences Ltd Details 2.10.2 Glenmark Life Sciences Ltd Major Business 2.10.3 Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services 2.10.4 Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.10.5 Glenmark Life Sciences Ltd Recent Developments/Updates 2.11 Alembic Pharmaceuticals Ltd 2.11.1 Alembic Pharmaceuticals Ltd Details 2.11.2 Alembic Pharmaceuticals Ltd Major Business 2.11.3 Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Product and Services 2.11.4 Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.11.5 Alembic Pharmaceuticals Ltd Recent Developments/Updates 2.12 Msn Laboratories Private Ltd 2.12.1 Msn Laboratories Private Ltd Details 2.12.2 Msn Laboratories Private Ltd Major Business 2.12.3 Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Product and Services 2.12.4 Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.12.5 Msn Laboratories Private Ltd Recent Developments/Updates 2.13 Metrochem Api Private Ltd 2.13.1 Metrochem Api Private Ltd Details 2.13.2 Metrochem Api Private Ltd Major Business 2.13.3 Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Product and Services 2.13.4 Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.13.5 Metrochem Api Private Ltd Recent Developments/Updates 2.14 Lee Pharma Ltd 2.14.1 Lee Pharma Ltd Details 2.14.2 Lee Pharma Ltd Major Business 2.14.3 Lee Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services 2.14.4 Lee Pharma Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.14.5 Lee Pharma Ltd Recent Developments/Updates 2.15 Msn Life Sciences Private Ltd 2.15.1 Msn Life Sciences Private Ltd Details 2.15.2 Msn Life Sciences Private Ltd Major Business 2.15.3 Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Product and Services 2.15.4 Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.15.5 Msn Life Sciences Private Ltd Recent Developments/Updates 2.16 Optimus Drugs Private Ltd 2.16.1 Optimus Drugs Private Ltd Details 2.16.2 Optimus Drugs Private Ltd Major Business 2.16.3 Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Product and Services 2.16.4 Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.16.5 Optimus Drugs Private Ltd Recent Developments/Updates 2.17 Yabao Pharmaceutical Group Co Ltd 2.17.1 Yabao Pharmaceutical Group Co Ltd Details 2.17.2 Yabao Pharmaceutical Group Co Ltd Major Business 2.17.3 Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Product and Services 2.17.4 Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.17.5 Yabao Pharmaceutical Group Co Ltd Recent Developments/Updates 2.18 Acebright India Pharma Private Ltd 2.18.1 Acebright India Pharma Private Ltd Details 2.18.2 Acebright India Pharma Private Ltd Major Business 2.18.3 Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Product and Services 2.18.4 Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.18.5 Acebright India Pharma Private Ltd Recent Developments/Updates 2.19 Srini Pharmaceuticals Private Ltd 2.19.1 Srini Pharmaceuticals Private Ltd Details 2.19.2 Srini Pharmaceuticals Private Ltd Major Business 2.19.3 Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Product and Services 2.19.4 Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.19.5 Srini Pharmaceuticals Private Ltd Recent Developments/Updates 2.20 Biocon Ltd 2.20.1 Biocon Ltd Details 2.20.2 Biocon Ltd Major Business 2.20.3 Biocon Ltd Dabigatran Etexilate Mesylate API Product and Services 2.20.4 Biocon Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.20.5 Biocon Ltd Recent Developments/Updates 2.21 Jubilant Generics Ltd 2.21.1 Jubilant Generics Ltd Details 2.21.2 Jubilant Generics Ltd Major Business 2.21.3 Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Product and Services 2.21.4 Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.21.5 Jubilant Generics Ltd Recent Developments/Updates 2.22 Solara Active Pharma Sciences Ltd 2.22.1 Solara Active Pharma Sciences Ltd Details 2.22.2 Solara Active Pharma Sciences Ltd Major Business 2.22.3 Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services 2.22.4 Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.22.5 Solara Active Pharma Sciences Ltd Recent Developments/Updates 2.23 Piramal Pharma Ltd 2.23.1 Piramal Pharma Ltd Details 2.23.2 Piramal Pharma Ltd Major Business 2.23.3 Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services 2.23.4 Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.23.5 Piramal Pharma Ltd Recent Developments/Updates 2.24 Micro Labs Ltd 2.24.1 Micro Labs Ltd Details 2.24.2 Micro Labs Ltd Major Business 2.24.3 Micro Labs Ltd Dabigatran Etexilate Mesylate API Product and Services 2.24.4 Micro Labs Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.24.5 Micro Labs Ltd Recent Developments/Updates 2.25 Sun Pharmaceutical Industries Ltd 2.25.1 Sun Pharmaceutical Industries Ltd Details 2.25.2 Sun Pharmaceutical Industries Ltd Major Business 2.25.3 Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services 2.25.4 Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.25.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates 2.26 Zhejiang Huahai Pharmaceutical Co Ltd 2.26.1 Zhejiang Huahai Pharmaceutical Co Ltd Details 2.26.2 Zhejiang Huahai Pharmaceutical Co Ltd Major Business 2.26.3 Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services 2.26.4 Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.26.5 Zhejiang Huahai Pharmaceutical Co Ltd Recent Developments/Updates 2.27 Sichuan Qingmu Pharmaceutical Co Ltd 2.27.1 Sichuan Qingmu Pharmaceutical Co Ltd Details 2.27.2 Sichuan Qingmu Pharmaceutical Co Ltd Major Business 2.27.3 Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services 2.27.4 Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.27.5 Sichuan Qingmu Pharmaceutical Co Ltd Recent Developments/Updates 2.28 Jiangxi Synergy Pharmaceutical Co Ltd 2.28.1 Jiangxi Synergy Pharmaceutical Co Ltd Details 2.28.2 Jiangxi Synergy Pharmaceutical Co Ltd Major Business 2.28.3 Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services 2.28.4 Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.28.5 Jiangxi Synergy Pharmaceutical Co Ltd Recent Developments/Updates 2.29 Changzhou Pharmaceutical Factory 2.29.1 Changzhou Pharmaceutical Factory Details 2.29.2 Changzhou Pharmaceutical Factory Major Business 2.29.3 Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Product and Services 2.29.4 Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.29.5 Changzhou Pharmaceutical Factory Recent Developments/Updates 2.30 Hisun Pharmaceutical Nantong Co Ltd 2.30.1 Hisun Pharmaceutical Nantong Co Ltd Details 2.30.2 Hisun Pharmaceutical Nantong Co Ltd Major Business 2.30.3 Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Product and Services 2.30.4 Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.30.5 Hisun Pharmaceutical Nantong Co Ltd Recent Developments/Updates 3 Competitive Environment: Dabigatran Etexilate Mesylate API by Manufacturer 3.1 Global Dabigatran Etexilate Mesylate API Sales Quantity by Manufacturer (2018-2023) 3.2 Global Dabigatran Etexilate Mesylate API Revenue by Manufacturer (2018-2023) 3.3 Global Dabigatran Etexilate Mesylate API Average Price by Manufacturer (2018-2023) 3.4 Market Share Analysis (2022) 3.4.1 Producer Shipments of Dabigatran Etexilate Mesylate API by Manufacturer Revenue ($MM) and Market Share (%): 2022 3.4.2 Top 3 Dabigatran Etexilate Mesylate API Manufacturer Market Share in 2022 3.4.2 Top 6 Dabigatran Etexilate Mesylate API Manufacturer Market Share in 2022 3.5 Dabigatran Etexilate Mesylate API Market: Overall Company Footprint Analysis 3.5.1 Dabigatran Etexilate Mesylate API Market: Region Footprint 3.5.2 Dabigatran Etexilate Mesylate API Market: Company Product Type Footprint 3.5.3 Dabigatran Etexilate Mesylate API Market: Company Product Application Footprint 3.6 New Market Entrants and Barriers to Market Entry 3.7 Mergers, Acquisition, Agreements, and Collaborations 4 Consumption Analysis by Region 4.1 Global Dabigatran Etexilate Mesylate API Market Size by Region 4.1.1 Global Dabigatran Etexilate Mesylate API Sales Quantity by Region (2018-2029) 4.1.2 Global Dabigatran Etexilate Mesylate API Consumption Value by Region (2018-2029) 4.1.3 Global Dabigatran Etexilate Mesylate API Average Price by Region (2018-2029) 4.2 North America Dabigatran Etexilate Mesylate API Consumption Value (2018-2029) 4.3 Europe Dabigatran Etexilate Mesylate API Consumption Value (2018-2029) 4.4 Asia-Pacific Dabigatran Etexilate Mesylate API Consumption Value (2018-2029) 4.5 South America Dabigatran Etexilate Mesylate API Consumption Value (2018-2029) 4.6 Middle East and Africa Dabigatran Etexilate Mesylate API Consumption Value (2018-2029) 5 Market Segment by Type 5.1 Global Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2029) 5.2 Global Dabigatran Etexilate Mesylate API Consumption Value by Type (2018-2029) 5.3 Global Dabigatran Etexilate Mesylate API Average Price by Type (2018-2029) 6 Market Segment by Application 6.1 Global Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2029) 6.2 Global Dabigatran Etexilate Mesylate API Consumption Value by Application (2018-2029) 6.3 Global Dabigatran Etexilate Mesylate API Average Price by Application (2018-2029) 7 North America 7.1 North America Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2029) 7.2 North America Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2029) 7.3 North America Dabigatran Etexilate Mesylate API Market Size by Country 7.3.1 North America Dabigatran Etexilate Mesylate API Sales Quantity by Country (2018-2029) 7.3.2 North America Dabigatran Etexilate Mesylate API Consumption Value by Country (2018-2029) 7.3.3 United States Market Size and Forecast (2018-2029) 7.3.4 Canada Market Size and Forecast (2018-2029) 7.3.5 Mexico Market Size and Forecast (2018-2029) 8 Europe 8.1 Europe Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2029) 8.2 Europe Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2029) 8.3 Europe Dabigatran Etexilate Mesylate API Market Size by Country 8.3.1 Europe Dabigatran Etexilate Mesylate API Sales Quantity by Country (2018-2029) 8.3.2 Europe Dabigatran Etexilate Mesylate API Consumption Value by Country (2018-2029) 8.3.3 Germany Market Size and Forecast (2018-2029) 8.3.4 France Market Size and Forecast (2018-2029) 8.3.5 United Kingdom Market Size and Forecast (2018-2029) 8.3.6 Russia Market Size and Forecast (2018-2029) 8.3.7 Italy Market Size and Forecast (2018-2029) 9 Asia-Pacific 9.1 Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2029) 9.2 Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2029) 9.3 Asia-Pacific Dabigatran Etexilate Mesylate API Market Size by Region 9.3.1 Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity by Region (2018-2029) 9.3.2 Asia-Pacific Dabigatran Etexilate Mesylate API Consumption Value by Region (2018-2029) 9.3.3 China Market Size and Forecast (2018-2029) 9.3.4 Japan Market Size and Forecast (2018-2029) 9.3.5 Korea Market Size and Forecast (2018-2029) 9.3.6 India Market Size and Forecast (2018-2029) 9.3.7 Southeast Asia Market Size and Forecast (2018-2029) 9.3.8 Australia Market Size and Forecast (2018-2029) 10 South America 10.1 South America Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2029) 10.2 South America Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2029) 10.3 South America Dabigatran Etexilate Mesylate API Market Size by Country 10.3.1 South America Dabigatran Etexilate Mesylate API Sales Quantity by Country (2018-2029) 10.3.2 South America Dabigatran Etexilate Mesylate API Consumption Value by Country (2018-2029) 10.3.3 Brazil Market Size and Forecast (2018-2029) 10.3.4 Argentina Market Size and Forecast (2018-2029) 11 Middle East & Africa 11.1 Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2029) 11.2 Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2029) 11.3 Middle East & Africa Dabigatran Etexilate Mesylate API Market Size by Country 11.3.1 Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity by Country (2018-2029) 11.3.2 Middle East & Africa Dabigatran Etexilate Mesylate API Consumption Value by Country (2018-2029) 11.3.3 Turkey Market Size and Forecast (2018-2029) 11.3.4 Egypt Market Size and Forecast (2018-2029) 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029) 11.3.6 South Africa Market Size and Forecast (2018-2029) 12 Market Dynamics 12.1 Dabigatran Etexilate Mesylate API Market Drivers 12.2 Dabigatran Etexilate Mesylate API Market Restraints 12.3 Dabigatran Etexilate Mesylate API Trends Analysis 12.4 Porters Five Forces Analysis 12.4.1 Threat of New Entrants 12.4.2 Bargaining Power of Suppliers 12.4.3 Bargaining Power of Buyers 12.4.4 Threat of Substitutes 12.4.5 Competitive Rivalry 12.5 Influence of COVID-19 and Russia-Ukraine War 12.5.1 Influence of COVID-19 12.5.2 Influence of Russia-Ukraine War 13 Raw Material and Industry Chain 13.1 Raw Material of Dabigatran Etexilate Mesylate API and Key Manufacturers 13.2 Manufacturing Costs Percentage of Dabigatran Etexilate Mesylate API 13.3 Dabigatran Etexilate Mesylate API Production Process 13.4 Dabigatran Etexilate Mesylate API Industrial Chain 14 Shipments by Distribution Channel 14.1 Sales Channel 14.1.1 Direct to End-User 14.1.2 Distributors 14.2 Dabigatran Etexilate Mesylate API Typical Distributors 14.3 Dabigatran Etexilate Mesylate API Typical Customers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology 16.2 Research Process and Data Source 16.3 Disclaimer

List of Tables
Table 1. Global Dabigatran Etexilate Mesylate API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Dabigatran Etexilate Mesylate API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Hetero Drugs Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Hetero Drugs Ltd Major Business
Table 5. Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 6. Hetero Drugs Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Hetero Drugs Ltd Recent Developments/Updates
Table 8. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Aurobindo Pharma Ltd Major Business
Table 10. Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 11. Aurobindo Pharma Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Aurobindo Pharma Ltd Recent Developments/Updates
Table 13. Neuland Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Neuland Laboratories Ltd Major Business
Table 15. Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 16. Neuland Laboratories Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Neuland Laboratories Ltd Recent Developments/Updates
Table 18. Zydus Lifesciences Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Zydus Lifesciences Ltd Major Business
Table 20. Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 21. Zydus Lifesciences Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Zydus Lifesciences Ltd Recent Developments/Updates
Table 23. Alkem Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Alkem Laboratories Ltd Major Business
Table 25. Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 26. Alkem Laboratories Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Alkem Laboratories Ltd Recent Developments/Updates
Table 28. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Teva Pharmaceutical Industries Ltd Major Business
Table 30. Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 31. Teva Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 33. Lupin Ltd Basic Information, Manufacturing Base and Competitors
Table 34. Lupin Ltd Major Business
Table 35. Lupin Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 36. Lupin Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Lupin Ltd Recent Developments/Updates
Table 38. Dr Reddys Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Dr Reddys Laboratories Ltd Major Business
Table 40. Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 41. Dr Reddys Laboratories Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Dr Reddys Laboratories Ltd Recent Developments/Updates
Table 43. Apotex Pharmachem India Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Apotex Pharmachem India Pvt Ltd Major Business
Table 45. Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 46. Apotex Pharmachem India Pvt Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Apotex Pharmachem India Pvt Ltd Recent Developments/Updates
Table 48. Glenmark Life Sciences Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Glenmark Life Sciences Ltd Major Business
Table 50. Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 51. Glenmark Life Sciences Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Glenmark Life Sciences Ltd Recent Developments/Updates
Table 53. Alembic Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Alembic Pharmaceuticals Ltd Major Business
Table 55. Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 56. Alembic Pharmaceuticals Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Alembic Pharmaceuticals Ltd Recent Developments/Updates
Table 58. Msn Laboratories Private Ltd Basic Information, Manufacturing Base and Competitors
Table 59. Msn Laboratories Private Ltd Major Business
Table 60. Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 61. Msn Laboratories Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Msn Laboratories Private Ltd Recent Developments/Updates
Table 63. Metrochem Api Private Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Metrochem Api Private Ltd Major Business
Table 65. Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 66. Metrochem Api Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Metrochem Api Private Ltd Recent Developments/Updates
Table 68. Lee Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 69. Lee Pharma Ltd Major Business
Table 70. Lee Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 71. Lee Pharma Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Lee Pharma Ltd Recent Developments/Updates
Table 73. Msn Life Sciences Private Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Msn Life Sciences Private Ltd Major Business
Table 75. Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 76. Msn Life Sciences Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Msn Life Sciences Private Ltd Recent Developments/Updates
Table 78. Optimus Drugs Private Ltd Basic Information, Manufacturing Base and Competitors
Table 79. Optimus Drugs Private Ltd Major Business
Table 80. Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 81. Optimus Drugs Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Optimus Drugs Private Ltd Recent Developments/Updates
Table 83. Yabao Pharmaceutical Group Co Ltd Basic Information, Manufacturing Base and Competitors
Table 84. Yabao Pharmaceutical Group Co Ltd Major Business
Table 85. Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 86. Yabao Pharmaceutical Group Co Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Yabao Pharmaceutical Group Co Ltd Recent Developments/Updates
Table 88. Acebright India Pharma Private Ltd Basic Information, Manufacturing Base and Competitors
Table 89. Acebright India Pharma Private Ltd Major Business
Table 90. Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 91. Acebright India Pharma Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Acebright India Pharma Private Ltd Recent Developments/Updates
Table 93. Srini Pharmaceuticals Private Ltd Basic Information, Manufacturing Base and Competitors
Table 94. Srini Pharmaceuticals Private Ltd Major Business
Table 95. Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 96. Srini Pharmaceuticals Private Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Srini Pharmaceuticals Private Ltd Recent Developments/Updates
Table 98. Biocon Ltd Basic Information, Manufacturing Base and Competitors
Table 99. Biocon Ltd Major Business
Table 100. Biocon Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 101. Biocon Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Biocon Ltd Recent Developments/Updates
Table 103. Jubilant Generics Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Jubilant Generics Ltd Major Business
Table 105. Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 106. Jubilant Generics Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Jubilant Generics Ltd Recent Developments/Updates
Table 108. Solara Active Pharma Sciences Ltd Basic Information, Manufacturing Base and Competitors
Table 109. Solara Active Pharma Sciences Ltd Major Business
Table 110. Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 111. Solara Active Pharma Sciences Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Solara Active Pharma Sciences Ltd Recent Developments/Updates
Table 113. Piramal Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 114. Piramal Pharma Ltd Major Business
Table 115. Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 116. Piramal Pharma Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 117. Piramal Pharma Ltd Recent Developments/Updates
Table 118. Micro Labs Ltd Basic Information, Manufacturing Base and Competitors
Table 119. Micro Labs Ltd Major Business
Table 120. Micro Labs Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 121. Micro Labs Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 122. Micro Labs Ltd Recent Developments/Updates
Table 123. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 124. Sun Pharmaceutical Industries Ltd Major Business
Table 125. Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 126. Sun Pharmaceutical Industries Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 127. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 128. Zhejiang Huahai Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 129. Zhejiang Huahai Pharmaceutical Co Ltd Major Business
Table 130. Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 131. Zhejiang Huahai Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 132. Zhejiang Huahai Pharmaceutical Co Ltd Recent Developments/Updates
Table 133. Sichuan Qingmu Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Sichuan Qingmu Pharmaceutical Co Ltd Major Business
Table 135. Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 136. Sichuan Qingmu Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Sichuan Qingmu Pharmaceutical Co Ltd Recent Developments/Updates
Table 138. Jiangxi Synergy Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 139. Jiangxi Synergy Pharmaceutical Co Ltd Major Business
Table 140. Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 141. Jiangxi Synergy Pharmaceutical Co Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Jiangxi Synergy Pharmaceutical Co Ltd Recent Developments/Updates
Table 143. Changzhou Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 144. Changzhou Pharmaceutical FactoryMajor Business
Table 145. Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Product and Services
Table 146. Changzhou Pharmaceutical Factory Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 147. Changzhou Pharmaceutical Factory Recent Developments/Updates
Table 148. Hisun Pharmaceutical Nantong Co Ltd Basic Information, Manufacturing Base and Competitors
Table 149. Hisun Pharmaceutical Nantong Co Ltd Major Business
Table 150. Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Product and Services
Table 151. Hisun Pharmaceutical Nantong Co Ltd Dabigatran Etexilate Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 152. Hisun Pharmaceutical Nantong Co Ltd Recent Developments/Updates
Table 153. Global Dabigatran Etexilate Mesylate API Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 154. Global Dabigatran Etexilate Mesylate API Revenue by Manufacturer (2018-2023) & (USD Million)
Table 155. Global Dabigatran Etexilate Mesylate API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 156. Market Position of Manufacturers in Dabigatran Etexilate Mesylate API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 157. Head Office and Dabigatran Etexilate Mesylate API Production Site of Key Manufacturer
Table 158. Dabigatran Etexilate Mesylate API Market: Company Product Type Footprint
Table 159. Dabigatran Etexilate Mesylate API Market: Company Product Application Footprint
Table 160. Dabigatran Etexilate Mesylate API New Market Entrants and Barriers to Market Entry
Table 161. Dabigatran Etexilate Mesylate API Mergers, Acquisition, Agreements, and Collaborations
Table 162. Global Dabigatran Etexilate Mesylate API Sales Quantity by Region (2018-2023) & (Tons)
Table 163. Global Dabigatran Etexilate Mesylate API Sales Quantity by Region (2024-2029) & (Tons)
Table 164. Global Dabigatran Etexilate Mesylate API Consumption Value by Region (2018-2023) & (USD Million)
Table 165. Global Dabigatran Etexilate Mesylate API Consumption Value by Region (2024-2029) & (USD Million)
Table 166. Global Dabigatran Etexilate Mesylate API Average Price by Region (2018-2023) & (US$/Ton)
Table 167. Global Dabigatran Etexilate Mesylate API Average Price by Region (2024-2029) & (US$/Ton)
Table 168. Global Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 169. Global Dabigatran Etexilate Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 170. Global Dabigatran Etexilate Mesylate API Consumption Value by Type (2018-2023) & (USD Million)
Table 171. Global Dabigatran Etexilate Mesylate API Consumption Value by Type (2024-2029) & (USD Million)
Table 172. Global Dabigatran Etexilate Mesylate API Average Price by Type (2018-2023) & (US$/Ton)
Table 173. Global Dabigatran Etexilate Mesylate API Average Price by Type (2024-2029) & (US$/Ton)
Table 174. Global Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 175. Global Dabigatran Etexilate Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 176. Global Dabigatran Etexilate Mesylate API Consumption Value by Application (2018-2023) & (USD Million)
Table 177. Global Dabigatran Etexilate Mesylate API Consumption Value by Application (2024-2029) & (USD Million)
Table 178. Global Dabigatran Etexilate Mesylate API Average Price by Application (2018-2023) & (US$/Ton)
Table 179. Global Dabigatran Etexilate Mesylate API Average Price by Application (2024-2029) & (US$/Ton)
Table 180. North America Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 181. North America Dabigatran Etexilate Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 182. North America Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 183. North America Dabigatran Etexilate Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 184. North America Dabigatran Etexilate Mesylate API Sales Quantity by Country (2018-2023) & (Tons)
Table 185. North America Dabigatran Etexilate Mesylate API Sales Quantity by Country (2024-2029) & (Tons)
Table 186. North America Dabigatran Etexilate Mesylate API Consumption Value by Country (2018-2023) & (USD Million)
Table 187. North America Dabigatran Etexilate Mesylate API Consumption Value by Country (2024-2029) & (USD Million)
Table 188. Europe Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 189. Europe Dabigatran Etexilate Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 190. Europe Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 191. Europe Dabigatran Etexilate Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 192. Europe Dabigatran Etexilate Mesylate API Sales Quantity by Country (2018-2023) & (Tons)
Table 193. Europe Dabigatran Etexilate Mesylate API Sales Quantity by Country (2024-2029) & (Tons)
Table 194. Europe Dabigatran Etexilate Mesylate API Consumption Value by Country (2018-2023) & (USD Million)
Table 195. Europe Dabigatran Etexilate Mesylate API Consumption Value by Country (2024-2029) & (USD Million)
Table 196. Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 197. Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 198. Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 199. Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 200. Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity by Region (2018-2023) & (Tons)
Table 201. Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity by Region (2024-2029) & (Tons)
Table 202. Asia-Pacific Dabigatran Etexilate Mesylate API Consumption Value by Region (2018-2023) & (USD Million)
Table 203. Asia-Pacific Dabigatran Etexilate Mesylate API Consumption Value by Region (2024-2029) & (USD Million)
Table 204. South America Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 205. South America Dabigatran Etexilate Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 206. South America Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 207. South America Dabigatran Etexilate Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 208. South America Dabigatran Etexilate Mesylate API Sales Quantity by Country (2018-2023) & (Tons)
Table 209. South America Dabigatran Etexilate Mesylate API Sales Quantity by Country (2024-2029) & (Tons)
Table 210. South America Dabigatran Etexilate Mesylate API Consumption Value by Country (2018-2023) & (USD Million)
Table 211. South America Dabigatran Etexilate Mesylate API Consumption Value by Country (2024-2029) & (USD Million)
Table 212. Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 213. Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 214. Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 215. Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 216. Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity by Region (2018-2023) & (Tons)
Table 217. Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity by Region (2024-2029) & (Tons)
Table 218. Middle East & Africa Dabigatran Etexilate Mesylate API Consumption Value by Region (2018-2023) & (USD Million)
Table 219. Middle East & Africa Dabigatran Etexilate Mesylate API Consumption Value by Region (2024-2029) & (USD Million)
Table 220. Dabigatran Etexilate Mesylate API Raw Material
Table 221. Key Manufacturers of Dabigatran Etexilate Mesylate API Raw Materials
Table 222. Dabigatran Etexilate Mesylate API Typical Distributors
Table 223. Dabigatran Etexilate Mesylate API Typical Customers
List of Figures
Figure 1. Dabigatran Etexilate Mesylate API Picture
Figure 2. Global Dabigatran Etexilate Mesylate API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Dabigatran Etexilate Mesylate API Consumption Value Market Share by Type in 2022
Figure 4. Purity≥99% Examples
Figure 5. Purity<99% Examples
Figure 6. Global Dabigatran Etexilate Mesylate API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Dabigatran Etexilate Mesylate API Consumption Value Market Share by Application in 2022
Figure 8. Capsule Examples
Figure 9. Others Examples
Figure 10. Global Dabigatran Etexilate Mesylate API Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Dabigatran Etexilate Mesylate API Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Dabigatran Etexilate Mesylate API Sales Quantity (2018-2029) & (Tons)
Figure 13. Global Dabigatran Etexilate Mesylate API Average Price (2018-2029) & (US$/Ton)
Figure 14. Global Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Dabigatran Etexilate Mesylate API Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Dabigatran Etexilate Mesylate API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Dabigatran Etexilate Mesylate API Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Dabigatran Etexilate Mesylate API Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Dabigatran Etexilate Mesylate API Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Dabigatran Etexilate Mesylate API Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Dabigatran Etexilate Mesylate API Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Dabigatran Etexilate Mesylate API Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Dabigatran Etexilate Mesylate API Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Dabigatran Etexilate Mesylate API Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Dabigatran Etexilate Mesylate API Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Dabigatran Etexilate Mesylate API Average Price by Type (2018-2029) & (US$/Ton)
Figure 29. Global Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Dabigatran Etexilate Mesylate API Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Dabigatran Etexilate Mesylate API Average Price by Application (2018-2029) & (US$/Ton)
Figure 32. North America Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Dabigatran Etexilate Mesylate API Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Dabigatran Etexilate Mesylate API Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Dabigatran Etexilate Mesylate API Consumption Value Market Share by Region (2018-2029)
Figure 52. China Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Dabigatran Etexilate Mesylate API Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Dabigatran Etexilate Mesylate API Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Dabigatran Etexilate Mesylate API Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Dabigatran Etexilate Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)_x000D

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のメシル酸レンバチニブ市場2023年：企業・地域・タイプ・用途別分析
  • ダビガトランエテキシレートカプセルのグローバル市場2023：110mg/カプセル、150mg/カプセル
  • 世界のメシル酸レンバチニブカプセル市場2023年：企業・地域・タイプ・用途別分析
  • ダビガトランエテキシレートカプセルの世界市場2023-2029：110mg/カプセル、150mg/カプセル
  • 世界の高純度ポリビニルアルコールPVA市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM0468 )"世界のダビガトランエテキシレートメシル酸API市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Dabigatran Etexilate Mesylate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。